Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Concert Pharmaceuticals Company Profile (NASDAQ:CNCE)

Consensus Ratings for Concert Pharmaceuticals (NASDAQ:CNCE) (?)
Ratings Breakdown: 2 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $21.00 (46.85% upside)

Analysts' Ratings History for Concert Pharmaceuticals (NASDAQ:CNCE)
Show:
DateFirmActionRatingPrice TargetActions
5/20/2015Roth CapitalReiterated RatingBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015ZacksDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015Roth CapitalReiterated RatingBuy$19.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015TheStreetUpgradeSell -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015ZacksUpgradeHold -> Buy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2015Roth CapitalSet Price TargetBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2014Roth CapitalLower Price TargetBuy$28.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/8/2014Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2014Ladenburg ThalmannInitiated CoverageBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/29/2014Roth CapitalInitiated CoverageBuy$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2014Roth CapitalInitiated CoverageBuy$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2014Wells Fargo & Co.Initiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2014JMP SecuritiesInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2013 forward)